Mark Therapeutics Revenue

Biotechnology Research • 9276 Scranton Rd, Suite 500, United States • 1-10 Employees

Mark Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Mark Therapeutics

Victoria Bolotina

President and CSO

Company overview

Headquarters	9276 Scranton Rd, Suite 500, San Diego, California 92121, US
Website	marktherapeutics.com
NAICS	541714
Employees	1-10

Mark Therapeutics Email Formats

Mark Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@marktherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@marktherapeutics.com	100%

About Mark Therapeutics

Mark Therapeutics is a preclinical stage biotech company developing first-in-class disease-modifying Gene Therapy to halt the progression of currently incurable idiopathic Parkinson's Disease which represents ~80% of all Parkinson’s cases. We focus on restoring critical cellular function upstream from the classical Parkinson's targets that can prevent pathological loss of dopaminergic neurons in the brain and address the unmet needs of idiopathic Parkinson's patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Funding Data

Mark Therapeutics has never raised funding before.

Mark Therapeutics Tech Stack

Discover the technologies and tools that power Mark Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Onsen UI

Mobile frameworks

Consent Manager

Cookie compliance

Google Tag Manager

Tag managers

Nginx

Reverse proxies

OpenResty

Web servers

Microsoft 365

Frequently asked questions

Mark Therapeutics is located in 9276 Scranton Rd, Suite 500, US.

Mark Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Mark Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Mark Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Mark Therapeutics

Victoria Bolotina

President and CSO

4.8

40,000 users